Bluebird -3% AH on $100M offering

|By:, SA News Editor

Bluebird bio (BLUE) plans to sell $100M worth of shares through a public offering. Underwriters will have a $15M overallotment option.

The gene therapy developer had $192.5M in cash as of March 31, and no debt.